Matches in Nanopublications for { ?s ?p "[The data have provided clues as to the importance of these molecules in the progression of breast cancer and specifically identified EphB6, a kinase-deficient receptor, which is downregulated in the most aggressive cell line, as reported for several other cancer types including neuroblastoma and melanoma suggesting its potential as a prognostic indicator in breast cancer as well.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP377263.RAUNCXA2zZoSxKi_aLgZop7cuW3esZW1m3CtQZUdZo8-Q130_assertion description "[The data have provided clues as to the importance of these molecules in the progression of breast cancer and specifically identified EphB6, a kinase-deficient receptor, which is downregulated in the most aggressive cell line, as reported for several other cancer types including neuroblastoma and melanoma suggesting its potential as a prognostic indicator in breast cancer as well.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP377263.RAUNCXA2zZoSxKi_aLgZop7cuW3esZW1m3CtQZUdZo8-Q130_provenance.
- NP377215.RA3SfI7bd0pmY1DVa74MTYntKR2eUh6J6cY9mWnFQThXs130_assertion description "[The data have provided clues as to the importance of these molecules in the progression of breast cancer and specifically identified EphB6, a kinase-deficient receptor, which is downregulated in the most aggressive cell line, as reported for several other cancer types including neuroblastoma and melanoma suggesting its potential as a prognostic indicator in breast cancer as well.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP377215.RA3SfI7bd0pmY1DVa74MTYntKR2eUh6J6cY9mWnFQThXs130_provenance.
- NP377239.RA9_SOk_usrAopJjk09xZ4WN1-5AsP73p4qT-zeuZzCks130_assertion description "[The data have provided clues as to the importance of these molecules in the progression of breast cancer and specifically identified EphB6, a kinase-deficient receptor, which is downregulated in the most aggressive cell line, as reported for several other cancer types including neuroblastoma and melanoma suggesting its potential as a prognostic indicator in breast cancer as well.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP377239.RA9_SOk_usrAopJjk09xZ4WN1-5AsP73p4qT-zeuZzCks130_provenance.
- NP444462.RAKPd62jmGb9vGBxwuPZIX1Pk18QgGjDaz6zTgtKNOLuk130_assertion description "[The data have provided clues as to the importance of these molecules in the progression of breast cancer and specifically identified EphB6, a kinase-deficient receptor, which is downregulated in the most aggressive cell line, as reported for several other cancer types including neuroblastoma and melanoma suggesting its potential as a prognostic indicator in breast cancer as well.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP444462.RAKPd62jmGb9vGBxwuPZIX1Pk18QgGjDaz6zTgtKNOLuk130_provenance.
- NP444464.RAN2wF4QVocYqCtLwA6ueXVXlvNN5JEphEBixJIBXd_xQ130_assertion description "[The data have provided clues as to the importance of these molecules in the progression of breast cancer and specifically identified EphB6, a kinase-deficient receptor, which is downregulated in the most aggressive cell line, as reported for several other cancer types including neuroblastoma and melanoma suggesting its potential as a prognostic indicator in breast cancer as well.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP444464.RAN2wF4QVocYqCtLwA6ueXVXlvNN5JEphEBixJIBXd_xQ130_provenance.
- NP444466.RArOgHEPgS0y5Yllq5RjJPre4e1ZOx7eW7Ynf_LyAK0BM130_assertion description "[The data have provided clues as to the importance of these molecules in the progression of breast cancer and specifically identified EphB6, a kinase-deficient receptor, which is downregulated in the most aggressive cell line, as reported for several other cancer types including neuroblastoma and melanoma suggesting its potential as a prognostic indicator in breast cancer as well.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP444466.RArOgHEPgS0y5Yllq5RjJPre4e1ZOx7eW7Ynf_LyAK0BM130_provenance.